Artelo Biosciences Inc.
ARTL | NASDAQ
$4.15
+$0.05 (+1.22%)
At close: Sep 22, 2026, 4:00 PM ET
$4.11
-$0.04 (-0.94%)
After-hours:
Sep 22, 2026, 7:59 PM ET
Market Data
Market Cap $1.59M
Enterprise Value $-2.56M
Beta -0.08
Average Volume 112.33K
Shares Outstanding (Diluted) 2.71M
Shares Change YoY 57.49%
Institutional Ownership 6.17%
Exchange NASDAQ
ISIN US04301G8050
Price Performance
Price Change 1M -32.9%
Price Change 3M -63.8%
Price Change 6M -90.6%
Price Change YTD -64.1%
Price Change 1Y -92.3%
Price Change 3Y -95.1%
Price Change 5Y -99.4%
1M CAGR (ann.) -36.8%
1Y CAGR (ann.) -91.8%
5Y CAGR (ann.) -64.3%
All-Time CAGR -60.9%
Valuation
PE Ratio -0.50
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS 0.00
PB Ratio 0.32
P/FCF Ratio -0.13
P/Adj. FCF Ratio -0.11
P/OCF Ratio -0.10
EV/Sales N/A
EV/EBIT 0.21
EV/EBITDA 0.21
EV/FCF 0.20
Earnings Yield -201.2%
FCF Yield -795.6%
Adj. FCF Yield -907.1%
Financial Health
Net Cash $4.15M
Total Debt $49K
Cash & Short-Term Investments $4.2M
Total Assets $6.46M
Current Ratio 3.00
Quick Ratio 3.00
Debt / Equity Ratio 0.01
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -257.82
Interest Coverage -17.91
Altman Z-Score -19.79
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -14.0%
Returns
Return on Assets -196.2%
Return on Equity -519.1%
Return on Invested Capital -219.4%
Return on Capital Employed -221.2%
Return on Tangible Assets -286.7%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -53.5%
EPS CAGR 5Y -51.5%
EPS CAGR 10Y -8.5%
FCF CAGR 3Y -17.7%
FCF CAGR 5Y -9.4%
FCF CAGR 10Y -19.5%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 1
EPS Growth Next 3Y 1129.7%
Revenue Growth Next 3Y N/A
Earnings Date Nov 16, 2026
EPS Estimate (next Q) -$7.02
EPS Growth Est (next Q) -41.1%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-12.63M
Free Cash Flow $-12.63M
Adj. Free Cash Flow $-14.4M
FCF Per Share -$41.92
OCF Per Share -$41.92
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-11.07M
EBITDA $-12.05M
Net Income $-12.67M
EPS (Diluted) -$8.25
Revenue / Employee N/A
Profit / Employee $-1.81M
Employees 7
Add to Watchlist
Select watchlists to add or remove ARTL